Global Diagnostics Market Overview, Size, Share and Trends 2018-2026
Summary – A new market study, “COVID-19
Diagnostics: Global Markets”has been featured on WiseGuyReports.
The current
report offers a detailed picture of the market for COVID-19 diagnostics.
COVID-19 is
an infectious disease that is caused by the coronavirus and primarily affects
the lungs.
This report
highlights the current and future market potential for COVID-19 diagnostics and
provides a detailed analysis of the competitive environment, regulatory
scenario, drivers, restraints, opportunities and trends in the market. The
report also covers market projections through 2027, as well as market shares
for key market players.
This report
details market shares for COVID-19 diagnostics based on type, technology,
end-user and geography. Based on type, the market is segmented into molecular
tests and serology tests segments. Based on technology, the market is segmented
into reverse transcription polymerase chain reaction (RT-PCR), isothermal
amplification, clustered regularly interspaced short palindromic repeats
(CRISPR), enzyme-linked immunosorbent assay (ELISA), hybridization and others.
By geography,
the market has been segmented into North America, Europe, Asia-Pacific, Latin
America, and the Middle East and Africa. Detailed analyses of major countries
(the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and
India) are covered in regional segments. For market estimates, data has been
provided for 2020 as the base year, with forecasts for 2021 through 2027.
Estimated values are based on diagnostics manufacturers' total revenues.
Projected and forecasted revenue values are in constant U.S. dollars,
unadjusted for inflation.
Report
Includes:
- 56 data
tables and 39 additional tables
- An overview
of the global market for COVID-19 diagnostics
- Estimation
of the market size of global COVID-19 diagnostics and analyses of global market
trends, with estimated data from 2020, 2021 and projections of compound annual
growth rates (CAGRs) through 2027
- Explanation
of factors driving and restraining the growth of global COVID-19 diagnostics
market
- A look at
the Case-Fatality Rate (CFR), global confirmed cases and confirmed deaths due
to COVID-19 and COVID-19 clinical trial landscape
- Information
on potential targets for COVID-19 drug development such as Basigin (CD147), C-C
Chemokine Receptor Type 5 (CCR5) and many more
- Details
about collaboration between organizations and governments to stop this pandemic
and recent research and development activities for COVID-19
- Market
share analysis of the key companies of the industry, their strategic profiling
and key competitive landscape
- Detailed
company profiles of market leading participants, including Abbott, Danaher
Corp., Bio-Rad Laboratories Inc., F. Hoffman-La Roche Ltd., and Thermo Fisher
Scientific Inc.Summary:
The global
market for COVID-19 diagnostics was valued at REDACTED in 2020. The market is
expected to grow at a compound annual growth rate (CAGR) of REDACTED to reach
REDACTED by 2027. Growth of the global market is attributed growth due to
increasing COVID-19 cases, increasing initiatives by governments to improve
patient care, rising adoption of rapid test kits among healthcare professionals
and strong investment into research and development activities by key market
players, including Becton, Dickinson and Co., Abbott, Bio-Rad Laboratories,
Danaher, F. Hoffmann-La Roche Ltd., Siemens Healthcare AG and others.
Increasing
consumer preference for new, cost-effective COVID-19 diagnostic products comes
with the substantial increase in the prevalence of COVID-19 in the U.S. The
U.S. is one of the major markets for diagnostics. According to info from
Worldometer, the U.S. accounts for approximately REDACTED of COVID-19 cases as
of July 6, 2020, and major companies in the market are engaging in R&D of
diagnostic testkits as government agencies are testing patients with COVID-19
symptoms aggressively in the U.S. Theincreased number of COVID-19 patients is
likely to drive the market for COVID-19 diagnostics during theforecast
period.1DROP DIAGNOSTICS
ABBOTT
BECTON,
DICKINSON AND CO.
BIO-RAD
LABORATORIES INC.
BIOMERIEUX SA
CEPHEID
DANAHER CORP.
F.
HOFFMANN-LA ROCHE LTD.
GENMARK
DIAGNOSTICS INC.
HOLOGIC INC.
LABORATORY
CORPORATION OF AMERICA HOLDINGS
PERKINELMER
INC.
QIAGEN NV
QUEST
DIAGNOSTICS
SIEMENS
HEALTHCARE AG
THERMO FISHER
SCIENTIFIC INC.
VEREDUS
LABORATORIES
FOR MORE DETAILS : https://www.wiseguyreports.com/reports/5611302-covid-19-diagnostics-global-markets
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH
TRENT
Ph: +162-825-80070
(US)
Ph: +44 2035002763 (UK)
Comments
Post a Comment